T1	Outcomes 849 870	overall survival (OS)
T2	Outcomes 904 913	Median OS
T3	Outcomes 1083 1129	Median progression-free survival (PFS, months)
T4	Outcomes 1342 1359	longer OS and PFS
T5	Outcomes 1578 1588	OS and PFS
T6	Outcomes 1715 1744	Pemetrexed-cisplatin toxicity
T7	Outcomes 1885 1893	survival
T8	Outcomes 2004 2024	OS and PFS advantage
